Correlation Between Day One and Bioatla

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Day One and Bioatla at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Bioatla into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Bioatla, you can compare the effects of market volatilities on Day One and Bioatla and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Bioatla. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Bioatla.

Diversification Opportunities for Day One and Bioatla

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Day and Bioatla is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Bioatla in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bioatla and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Bioatla. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bioatla has no effect on the direction of Day One i.e., Day One and Bioatla go up and down completely randomly.

Pair Corralation between Day One and Bioatla

Given the investment horizon of 90 days Day One is expected to generate 28.56 times less return on investment than Bioatla. But when comparing it to its historical volatility, Day One Biopharmaceuticals is 2.31 times less risky than Bioatla. It trades about 0.0 of its potential returns per unit of risk. Bioatla is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  200.00  in Bioatla on September 14, 2024 and sell it today you would lose (55.50) from holding Bioatla or give up 27.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Day One Biopharmaceuticals  vs.  Bioatla

 Performance 
       Timeline  
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Bioatla 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bioatla has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Bioatla is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Day One and Bioatla Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Day One and Bioatla

The main advantage of trading using opposite Day One and Bioatla positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Bioatla can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioatla will offset losses from the drop in Bioatla's long position.
The idea behind Day One Biopharmaceuticals and Bioatla pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Commodity Directory
Find actively traded commodities issued by global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities